Julie J. Miller

Also affiliated with Massachusetts General Hospital, Center for Neuro-Oncology, Global Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma”.

Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma

Cancer Cell(2024)10.1016/j.ccell.2024.03.008

N/A

0.614DataRank · unranked

59 citations

Simon Gritsch, Masashi Nomura, Alexander Jucht, Jérôme Fortin, Ramya Raviram +25 more

Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma

Neuro-Oncology(2025)10.1093/neuonc/noaf287

N/A

0.241DataRank · unranked

4 citations

Elisa Aquilanti, Julie J. Miller, Zhou Lan, Aleksandra B Lasica, Isabel Arrillaga‐Romany +20 more

Sirtuin activation targets IDH-mutant tumors

Neuro-Oncology(2020)10.1093/neuonc/noaa180

N/A

0DataRank · unranked

31 citations

Alexandria L. Fink, Jack A Banagis, Hiroaki Nagashima, Megha Subramanian, Christine K. Lee +6 more

MGMT promoter methylation and hypermutant recurrence in IDH mutant lower-grade glioma

Neuro-Oncology(2020)10.1093/neuonc/noaa212

N/A

0DataRank · unranked

6 citations

Daniel P. Cahill, Julie J. Miller

Prognostication in Acute Neurological Emergencies

Journal of Stroke and Cerebrovascular Diseases(2022)10.1016/j.jstrokecerebrovasdis.2021.106277

N/A

0DataRank · unranked

11 citations

Julie J. Miller, Amanda L. Piquet, Brian L. Edlow, Eric S. Rosenthal, Aneesh B. Singhal +1 more

IDH-mutant glioma: A new IDH1 inhibitor moves forward

Neuro-Oncology(2022)10.1093/neuonc/noac275

N/A

0DataRank · unranked

3 citations

Isabel Arrillaga‐Romany, Julie J. Miller

CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0562

N/A

0DataRank · unranked

23 citations

Lisa Melamed, Ethan A. Wetzel, Jenny Chia-Chen Chang, Hiroaki Nagashima, Yosuke Kitagawa +5 more

Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1056

N/A

0DataRank · unranked

11 citations

Leland G. Richardson, Jing Sun, Rishab Ramapriyan, Maria Martinez-Lage, Julie J. Miller +5 more

Suppression of antitumor immune signatures and upregulation of VEGFA as IDH-mutant gliomas progress to higher grade

Neurosurgical FOCUS(2024)10.3171/2023.11.focus23694

N/A

0DataRank · unranked

5 citations

Leland G. Richardson, Jing Sun, Rishab Ramapriyan, Maria Martinez-Lage, Julie J. Miller +4 more

Poly(ADP-ribose) Glycohydrolase Inhibition Sequesters NAD+ to Potentiate the Metabolic Lethality of Alkylating Chemotherapy in IDH-Mutant Tumor Cells

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0226

N/A

0DataRank · unranked

101 citations

Christine K. Lee, Kensuke Tateishi, Fumi Higuchi, Megha Subramanian, Seamus Rafferty +5 more

A Review of Emerging Immunotherapeutic Strategies for IDH-Mutant Glioma

Cancers(2025)10.3390/cancers17132178

N/A

0DataRank · unranked

3 citations

Eric P. Grewal, Rishab Ramapriyan, Leland G. Richardson, Gust Vandecandelaere, Adrian Kalaw +9 more

Patients’ Experiences With Staphylococcus aureus and Gram-negative Bacterial Bloodstream Infections: A Qualitative Descriptive Study and Concept Elicitation Phase To Inform Measurement of Patient-reported Quality of Life

Clinical Infectious Diseases(2020)10.1093/cid/ciaa611

N/A

0DataRank · unranked

31 citations

Sarah B. Doernberg, Julie J. Miller, Kiran Grover, Megan Oakes, Felicia Ruffin +12 more